Series C+ · 2026-11-17 · AI
Isomorphic Labs raises $5.00B
90
AI Score
Amount
$5.00B
Round
Series C+
Lead
Greenoaks, Sequoia Capital
HQ
London, GB
Why it matters: The round shows how much capital AI drug discovery can absorb before any candidate reaches human trials, and it sets Isomorphic's IsoDDE platform against a growing field of rivals.
Isomorphic Labs raised a $5B Series C co-led by Greenoaks and Sequoia, six months after its $2.1B Series B.
- Participants:
- Andreessen Horowitz (a16z), Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek, UK Sovereign AI Fund
- Source:
- Tech Funding News ↗ · Midu summary
Deal Dossier PRO
Pro feature
Deal Dossier for Isomorphic Labs
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
More deals with Greenoaks
Recent AI rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing